Small Molecule CMO/CDMO Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Small Molecule CMO/CDMO Market – Report Overview

Pacific Business Consulting’s “Small Molecule CMO/CDMO Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Small Molecule CMO/CDMO market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Small Molecule CMO/CDMO market exceeded a valuation of US$ 72.0 Billion and is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) surpassing 5.0% from 2023 to 2030. The market is anticipated to potentially surpass US$ 110.0 Billion by 2030.

Companies in the biotechnology and biopharmaceutical sectors enlist CMO/CDMO for development and production services, enabling them to significantly cut overall costs, save time, and streamline various processes. The importance of small molecules in advancing global therapeutic innovations remains prominent. Specialty medicines notably drive pharmaceutical industry growth globally, with small molecule applications contributing to over half of specialty sales. For example, according to the U.S. Food and Drug Administration (FDA) in 2022, small molecules accounted for approximately 59% of new drug approvals, with 22 of the 37 new drugs approved in 2022 being small molecules.

Biotechnology CDMOs/CMOs offer a wide range of services, including development, packaging, clinical supply, analytical testing, biomanufacturing, and fill finishing. Pharmaceutical, biopharma, and biotechnology companies collaborate with CDMOs to outsource drug research and manufacturing.

Cancer stands as a major global cause of death, and while treatable in the early stages, it poses a challenge beyond stage 2. The high burden of cancer prompts researchers to develop new treatment options, driving demand for CDMO services for small-molecule drugs. As of January 2023, ClinicalTrial.Gov reported over 11,465 studies registered for cancer research. Rising pricing pressure, regulatory challenges, and patent expiration are shrinking profit margins within the pharmaceutical industry.

Pharmaceutical companies consider outsourced services a “strategic competitive weapon” to overcome these challenges, saving expenses and time that can be directed towards facility operations and management. Contract development and manufacturing facilitate low-cost product development by reducing overall manufacturing costs. Additionally, outsourcing services help remove trade barriers and facilitate foreign market entry, thereby stimulating market growth.

Biopharmaceutical production is influenced by manufacturing scale, allowing the end user to adopt the entire biologics production process for commercial or clinical purposes. This study specifically examines clinical and commercial applications, measuring manufacturing capacity and income generated by biopharmaceutical contract manufacturing.

Key players in the Small Molecule CMO/CDMO segment, such as Siegfried Holding AG, Recipharm AB, Eurofins Scientific, Aurigene Pharmaceutical Services Ltd., CordenPharma International, Cambrex Corporation, Evotec, Bellen Chemistry, Lonza, Catalent, Inc, and Thermo Fisher Scientific Inc., are expected to play a crucial role in shaping the future landscape of Small Molecule CMO/CDMO technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Small Molecule CMO/CDMO market. It also delves into the analysis of present and prospective market competition within the global Small Molecule CMO/CDMO market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Small Molecule CMO/CDMO market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Small Molecule CMO/CDMO market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Small Molecule CMO/CDMO
   • Global Market Outlook: Small Molecule CMO/CDMO
2. Competitive Intelligence Analysis: Small Molecule CMO/CDMO
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Small Molecule CMO/CDMO
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Small Molecule CMO/CDMO
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Small Molecule CMO/CDMO: Ten Major Market (10MM) – Market Analysis, By Product Type
   • Active Pharmaceutical Ingredients (API)
   • Finished Drug Products (FDFs)
9. Small Molecule CMO/CDMO: Ten Major Market (10MM) – Market Analysis, By CMO/CDMO Size
   • Small
   • Mid-Size
   • Large
10. Small Molecule CMO/CDMO: Ten Major Market (10MM) – Market Analysis, By Services
    • GMP Manufacturing Service
    • Scale-Up and Tech Transfer
    • Process Development
    • Analytical Method Development
    • Quality Control and Quality Assurance
    • Regulatory Assistance
    • Technology and Innovation
    • Other Services
11. Small Molecule CMO/CDMO: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

12. S. Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

13. K. Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

14. Germany Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

15. France Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

16. Italy Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

17. Spain Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

18. Japan Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

19. China Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

20. Australia Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

21. India Small Molecule CMO/CDMO – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By CMO/CDMO Size
      • By Services
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By CMO/CDMO Size
      • By Services

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer